Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

European Union

This page shows the latest European Union news and features for those working in and with pharma, biotech and healthcare.

Moderna COVID-19 vaccine shortfall could affect UK supply

Moderna COVID-19 vaccine shortfall could affect UK supply

Moderna is working with Swiss company Lonza on the manufacturing of its vaccine, with the issues in the European supply chain believed to be the main cause of the delays. ... Reuters. Deliveries to the European Union and Switzerland are not affected by

Latest news

More from news
Approximately 5 fully matching, plus 306 partially matching documents found.

Latest Intelligence

  • A new era for UK-Japanese scientific research relations A new era for UK-Japanese scientific research relations

    This was the first trade deal reached by the United Kingdom following its departure from the European Union. ... Perhaps unsurprisingly, London is the most popular European city for Japanese residents to live in overseas and therefore gives a clear

  • An EU emergency health fund to limit the impact of future crises An EU emergency health fund to limit the impact of future crises

    risks. The ongoing and unprecedented public health crisis caused by COVID-19 has overstretched the structures and mechanisms of the European Union, especially those that deal with emergencies. ... Due to its financial innovation, not only does it

  • Biopharma and orphan drugs Biopharma and orphan drugs

    In the European Union, the Orphan Drug Regulation was adopted in 2000. ... Support success. According to Lavinia Meloni, spokeswoman for the European Federation of Pharmaceutical Industries and Associations, efforts to encourage development of drugs for

  • Industry needs an aligned position on the future of the EU OMP Regulation Industry needs an aligned position on the future of the EU OMP Regulation

    By Emma Eatwell. In March 2020 the European Commission presented its ‘New Industrial Strategy for Europe’, which proposes to move the European Union towards climate neutrality and digital leadership. ... The European Public Health Alliance says the

  • Pharma funding and M&A in 2020 Pharma funding and M&A in 2020

    Why pharma M&A has continually bucked the trend. Now that the UK has finally officially left the European Union, and with the dust having settled on a tumultuous end to ... But the one additional point I would make is to not assume the European or North

More from intelligence
Approximately 1 fully matching, plus 45 partially matching documents found.

Latest appointments

  • CureVac’s CEO appointed to EC High Level Group CureVac’s CEO appointed to EC High Level Group

    Dr Hoerr said: “It is a tremendous honor to be selected by the European Commission as member of the High Level Group focused on advancing innovation throughout the European Union. ... Governing board member of the European Institute for Innovation and

  • AZ's Lisa Anson elected president of ABPI AZ's Lisa Anson elected president of ABPI

    Lisa will play a leading role as we negotiate the future of our industry outside the European Union and as we work with government to build an industrial strategy with

  • EMVO appoints general manager EMVO appoints general manager

    Andreas Walter brings experience from the EFPIA. The European Medicines Verification Organisation (EMVO) has appointed Andreas Walter as its general manager. ... It was established last year by industry organisations, including EFPIA, and the European

  • Sonia Ruiz Moran appointed president of EMVO Sonia Ruiz Moran appointed president of EMVO

    The European Medicines Verification Organisation (EMVO) has appointed Sonia Ruiz Moran as its new president, replacing John Chave, former secretary general of Pharmaceutical Group of the European Union (PGEU). ... She said: “The planning and design of

  • IMI picks Ipsen's Marc de Garidel to chair governing board IMI picks Ipsen's Marc de Garidel to chair governing board

    De Garidel has been chairman and CEO of Ipsen, which specialises in neurology, endocrinology and urology-oncology, since 2010 and he chaired the European Biopharmaceutical Enterprises Association from 2010-12. ... The IMI is a public-private partnership

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • GLOBALHealthPR® Welcomes Exclusive France Partner Agency

    France is the second largest economy in the European Union and one of the largest consumers of pharmaceutical products in the world. ... As a member of the network, PRPA will work collaboratively alongside London-based European hub partner Aurora

  • What is everyone ‘ARPAing on about?

    On Wednesday 16th September, Ursula Von Der Leyen, President of the European Union, announced in her State of Union address that they plan to develop BARDA, a Biomedical Advanced Research and

  • Digital Therapeutics Landscape in Europe Digital Therapeutics Landscape in Europe

    HIGHLIGHTS INCLUDE:. Opportunities and threats of digital therapeutics after COVID-19. Digital therapeutics landscape in the European Union.

  • Hanover Communications Hanover Communications

    The European Commission’s Pharmaceutical Strategy has been published and the Commission has presented its priorities for the coming years. ... On Wednesday 16th September, Ursula Von Der Leyen, President of the European Union, announced in her State of

  • Behavioural insights to navigate complex healthcare markets

    The European Union alone spends 700bn  (£624 bn) annually on chronic disease management.

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....

Quick links